TREATMENT PERSISTENCE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA)

被引：0
|
作者：
Lyu, R. [1 ]
Ding, Q. [2 ]
Govoni, M. [3 ]
Fan, T. [1 ]
机构：
[1] Merck & Co Inc, Whitehouse Stn, NJ USA
[2] Temple Univ, Philadelphia, PA 19122 USA
[3] Merck Sharp & Dohme Ltd, Rome, Italy
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS68
引用
收藏
页码：A384 / A385
页数：3
相关论文
共 50 条
  • [1] TREATMENT PERSISTENCE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA)
    Lyu, R.
    Ding, Q.
    Govoni, M.
    Makin, C.
    Korn, J.
    Fan, T.
    Ogbonnaya, A.
    Black, C. M.
    Kachroo, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 357 - 357
  • [2] TREATMENT PERSISTENCE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Lyu, R.
    Govoni, M.
    Ding, Q.
    Fan, T.
    Ogbonnaya, A.
    Donga, P.
    Korn, J.
    Makin, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1162 - 1163
  • [3] The Persistence of Biologic Therapies for Psoriatic Arthritis
    Jasmen, Magdalena
    Garcia, Dominga
    Ibanez, Sebastian
    Diaz, Pamela
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2025, 31 (03) : 107 - 116
  • [4] Biologic therapies for the treatment of psoriatic arthritis
    Kim, Tae-Jong
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (02): : 124 - 129
  • [5] PERSISTENCE RATE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
    Lyu, R.
    Ding, Q.
    Govoni, M.
    Fan, T.
    VALUE IN HEALTH, 2014, 17 (07) : A384 - A384
  • [6] TREATMENT PERSISTENCE OF BIOLOGICS AMONG PATIENTS WITH PSORIATIC ARTHRITIS (PSA)
    Haddad, A.
    Gazitt, T.
    Feldhamer, I.
    Feld, J.
    Cohen, A.
    Zisman, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1684 - 1684
  • [7] TREATMENT PATTERNS AND PERSISTENCE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Govoni, M.
    Lyu, R.
    Ding, Q.
    Fan, T.
    Ogbonnaya, A.
    Donga, P.
    Korn, J.
    Makin, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1157 - 1157
  • [8] PERSISTENCE RATE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS)
    Lyu, R.
    Ding, Q.
    Govoni, M.
    Makin, C.
    Korn, J.
    Fan, T.
    Ogbonnaya, A.
    Black, C. M.
    Kachroo, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1151 - 1151
  • [9] PERSISTENCE RATE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS)
    Govoni, M.
    Lyu, R.
    Ding, Q.
    Fan, T.
    VALUE IN HEALTH, 2014, 17 (07) : A384 - A384
  • [10] PERSISTENCE IN USE OF BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS
    Jin, Y.
    Chen, S.
    Lee, H.
    Landon, J.
    Merola, J. F.
    Kim, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1689 - 1689
12345